Literature DB >> 29037907

Interleukin-22 in human inflammatory diseases and viral infections.

Arezoo Gowhari Shabgah1, Jamshid Gholizadeh Navashenaq2, Omid Gohari Shabgah3, Hamed Mohammadi4, Amirhossein Sahebkar5.   

Abstract

Interleukin-22 (IL22) is one of the members of IL10 family. Elevated levels of this cytokine can be seen in diseases caused by T lymphocytes, such as Psoriasis, Rheumatoid arthritis, interstitial lung diseases. IL22 is produced by different cells in both innate and acquired immunities. Different types of T cells are able to produce IL22, but the major IL22-producing T-cell is the TCD4. TH22 cell is a new line of TCD4 cells, which differentiated from naive T cells in the presence of TNFα and IL6; 50% of peripheral blood IL22 is produced by these cells. IL22 has important functions in host defense at mucosal surfaces as well as in tissue repair. In this review, we assess the current understanding of this cytokine and focus on the possible roles of IL-22 in autoimmune diseases.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Inflammatory disease; Interleukin 10 family; Interleukin 22; Multiple sclerosis; Viral infection

Mesh:

Substances:

Year:  2017        PMID: 29037907     DOI: 10.1016/j.autrev.2017.10.004

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  29 in total

1.  Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.

Authors:  Laurie S Conklin; Jesse M Damsker; Eric P Hoffman; William J Jusko; Panteleimon D Mavroudis; Benjamin D Schwartz; Laurel J Mengle-Gaw; Edward C Smith; Jean K Mah; Michela Guglieri; Yoram Nevo; Nancy Kuntz; Craig M McDonald; Mar Tulinius; Monique M Ryan; Richard Webster; Diana Castro; Richard S Finkel; Andrea L Smith; Lauren P Morgenroth; Adrienne Arrieta; Maya Shimony; Mark Jaros; Phil Shale; John M McCall; Yetrib Hathout; Kanneboyina Nagaraju; John van den Anker; Leanne M Ward; Alexandra Ahmet; Michaelyn R Cornish; Paula R Clemens
Journal:  Pharmacol Res       Date:  2018-09-13       Impact factor: 7.658

Review 2.  IL-20 receptor cytokines in autoimmune diseases.

Authors:  Jun Chen; Rachel R Caspi; Wai Po Chong
Journal:  J Leukoc Biol       Date:  2018-09-07       Impact factor: 4.962

3.  [Interleukin?22 promotes proliferation of fibroblast?like synoviocytes from patients with rheumatoid arthritis by inducing STAT3 phosphorylation].

Authors:  Jun-Qing Zhu; Ran Wang; Shi-Xian Chen; Di Zhao; Juan Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

Review 4.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

5.  Decreased Serum Level of Interleukin-22 Correlates with Hepcidin in Patients with Hidradenitis Suppurativa.

Authors:  Malgorzata Ponikowska; Łukasz Matusiak; Monika Kasztura; Ewa Jankowska; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2021-09-22       Impact factor: 3.875

6.  Aryl hydrocarbon receptor (Ahr)-dependent Il-22 expression by type 3 innate lymphoid cells control of acute joint inflammation.

Authors:  Ramzi Nehmar; Louis Fauconnier; Jose Alves-Filho; Dieudonnée Togbe; Aurore DeCauwer; Seiamak Bahram; Marc Le Bert; Bernhard Ryffel; Philippe Georgel
Journal:  J Cell Mol Med       Date:  2021-03-18       Impact factor: 5.310

7.  Interleukin 22 mitigates endothelial glycocalyx shedding after lipopolysaccharide injury.

Authors:  Sharven Taghavi; Sarah Abdullah; Juan Duchesne; Derek Pociask; Jay Kolls; Olan Jackson-Weaver
Journal:  J Trauma Acute Care Surg       Date:  2021-02-01       Impact factor: 3.697

8.  Mining zebrafish microbiota reveals key community-level resistance against fish pathogen infection.

Authors:  Franziska A Stressmann; Joaquín Bernal-Bayard; David Perez-Pascual; Bianca Audrain; Olaya Rendueles; Valérie Briolat; Sebastian Bruchmann; Stevenn Volant; Amine Ghozlane; Susanne Häussler; Eric Duchaud; Jean-Pierre Levraud; Jean-Marc Ghigo
Journal:  ISME J       Date:  2020-10-19       Impact factor: 10.302

9.  MicroRNA 452 regulates IL20RA-mediated JAK1/STAT3 pathway in inflammatory colitis and colorectal cancer.

Authors:  Santosh Lamichhane; Ji-Su Mo; Grinsun Sharma; Tae-Young Choi; Soo-Cheon Chae
Journal:  Inflamm Res       Date:  2021-07-20       Impact factor: 4.575

Review 10.  Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases.

Authors:  Qi Jiang; Guocan Yang; Fan Xiao; Jue Xie; Shengjun Wang; Liwei Lu; Dawei Cui
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.